Skip to main content
SpringerLink
Log in

Management of Infectious and Immunological Complications of Acquired Immunodeficiency Syndrome(AIDS)

Current and Future Prospects

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

AIDS is caused by a newly recognised virus (human immunodeficiency virus; HIV) which induces a profound defect in cellular immune function associated with increased susceptibility to opportunistic infections and certain malignancies. The clinical presentation of HIV ranges from asymptomatic infection to severe immunodeficiency manifesting as severe life-threatening infectious diseases or malignancies.

While major research efforts are being directed toward development of vaccine and discovery of effective antiretroviral drugs, clinicians are faced with AIDS patients with multiple and complicated medical problems including opportunistic infections and certain malignancies. Currently, efforts are directed toward early diagnosis, treatment, and pre-vention of recurrence of these opportunistic infections. The current approaches are reviewed in this article.

Major recent developments in AIDS research include the isolation of the HIV on culture and the availability of the antibody test. Aside from vaccine and antiretroviral drugs, other measures that may be of benefit in the treatment of AIDS patients are immunological enhancement and reconstitution. Several studies are underway to evaluate antiviral agents in the treatment of HIV infection. Those undergoing clinical trial include suramin, ribavirin, antimoniotungstate, phosphonoformate and azidothymidine. Immune enhancers that have been used include α-and γ-interferon and interleukin-2. HLA-matched lymphoctye transfusions and bone marrow transplantations have been used alone and in combination to replace the AIDS patient’s defective immune system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abrams DI, Kiprov DD, Goedert JJ. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Annals of Internal Medicine 104: 47–50, 1986

    PubMed  CAS  Google Scholar 

  • Abrams DI, Lewis BJ, Beckstead JH, et al. Persistent diffuse lymphodenopathy in homosexual men: Endpoint or prodrome. Annals of Internal Medicine 100: 801–808, 1984a

    PubMed  CAS  Google Scholar 

  • Abrams DI, Robia M, Blumenfeld W, et al. Disseminated coccidioidomycosis in AIDS. New Zealand Journal of Medicine 310: 986–987, 1984b

    CAS  Google Scholar 

  • Araujo FG, Remington JS. Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrobial Agents and Chemotherapy 5: 647–651, 1974

    PubMed  CAS  Google Scholar 

  • Bach MC, Bagwell SP, Knapp NP, et al. 9(l,3-dihydroxy-2-pro-poxymethyl) guanine for cytomegalovirus infections in patients with acquired immunodeficiency syndrome. Annals of Internal Medicine 103: 381–382, 1985

    PubMed  CAS  Google Scholar 

  • Balfour HH, Bean B, Laskin OL, et al. Acyclovir halts progression of herpes zoster in immunocompromised patients. New England Journal of Medicine 308: 1448–1453, 1983

    PubMed  Google Scholar 

  • Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 220: 868–871, 1983

    PubMed  CAS  Google Scholar 

  • Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 301: 126–131, 1979

    PubMed  CAS  Google Scholar 

  • Bowen DL, Lane HC, Fauci AS. Immunopathogenesis of the acquired immunodeficiency syndrome. Annals of Internal Medicine 103: 704–709, 1985

    PubMed  CAS  Google Scholar 

  • Breese Hall C, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. New England Journal of Medicine 308: 1443–1447, 1983

    Google Scholar 

  • Broder S, Collins JM, Markham PD, et al. Effects of suramin on HTVL-III/LAV infection presenting as Kaposi’s sarcoma or AIDS related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet 2: 627–630, 1985

    PubMed  CAS  Google Scholar 

  • Butler WT, Ailing DW, Spickard A, et al. Diagnostic and prognostic value of clinical laboratory findings in cryptococcal meningitis. New England Journal of Medicine 270: 59–67, 1964

    PubMed  CAS  Google Scholar 

  • Centers for Disease Control. Revision of the case definitions of acquired immunodeficiency syndrome for national reporting-United States. Morbidity and Mortality Weekly Report 34: 373–375, 1985

    Google Scholar 

  • Centers for Disease Control. Classification system for human T-lymphotropic virus type III/Lymphadenopathy-associated virus infections. Morbidity and Mortality Weekly Report 35: 334–339, 1986

    Google Scholar 

  • Centers for Disease Control Update. Public Health Service Workshop on Human T-lymphotropic Virus Type III Antibody Testing -3 United States. Morbidity and Mortality Weekly Report 34: 477–478, 1985

    Google Scholar 

  • Chermann JC, Sinoussi F, Jasmin C. Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. Biochemical and Biophysical Research Communications 65: 1229–1236, 1975

    PubMed  CAS  Google Scholar 

  • Coffin J, Haase A, Levy JA, et al. What to call the AIDS virus? Nature 321: 10, 1986

    PubMed  CAS  Google Scholar 

  • Collaborative DHPG Treatment Study Group: Treatment of serious cytomegalovirus infection with 9-(l,3-dihydroxy-2-pro-poxy methyl) guanine in patients with AIDS and other immunodeficiencies. New England Journal of Medicine 314: 801–805, 1986

    Google Scholar 

  • Cooper DA, Gold J, Maclean P, et al. Acute retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1: 537–540, 1985

    PubMed  CAS  Google Scholar 

  • Current WL, Reese NC, Ernst JV, et al. Human cryptosporidiosis in immunocompetent and immunodeficient persons: studies of an outbreak and experimental transmission. New England Journal of Medicine 308: 1252–1257, 1983

    PubMed  CAS  Google Scholar 

  • Davis KC, Hayward A, Otyiirk G, et al. Lymphocyte transfusion in case of acquired immunodeficiency syndrome. Lancet 1: 599–600, 1983

    PubMed  CAS  Google Scholar 

  • DeHovitz JA, Pape JW, Boncy M, et al. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 315: 87–90, 1986

    PubMed  CAS  Google Scholar 

  • Diamond RD, Bennett JE. A subcutaneous reservoir for intrathecal therapy of fungal meningitis. New England Journal of Medicine 288: 186–188, 1973

    PubMed  CAS  Google Scholar 

  • Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science 227: 1296–1303, 1985

    PubMed  CAS  Google Scholar 

  • Dormont D, Gourmelon P, Breton P, et al. Neurophysiological effects of tungsto-antimoniate HPA 23. Chemotherapy and Immunotherapy 2: 1071–1073, 1981

    Google Scholar 

  • Dormont D, Spire B, Barre-Sinoussi FC, et al. Inhibition of RNA dependent DNA polymerases of two primate retroviruses (LAV and AIDS virus) by ammonium-21-tungsto-9-antomoniate (HPA 23). Annales de 1’Institute Pasteur — Virologie, in press,1986

  • Egbert PR, Pollard RB, Gallagher JC, et al. Cytomegalovirus retinitis in immunosuppressed hosts: II Ocular manifestations. Annals of Internal Medicine 93: 664–670, 1980

    PubMed  CAS  Google Scholar 

  • Erikson B, Stening G, Oberg B. Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues. Antiviral Research 2: 81–85, 1982

    Google Scholar 

  • Eyles DE, Coleman N. An evaluation of pyrimethamine and sulfadiazine alone and in combination in experimental mouse toxoplasmosis. Antibiotics and Chemotherapy 5: 529–539, 1955

    CAS  Google Scholar 

  • Fauci A, Lane HC. Anti-retroviral therapy and immunological reconstitution in AIDS, in press, 1986

  • Fazio RA, Wickremesinghe PC, Arsura EL. Ketoconazole treatment of Candida esophagitis — a prospective study of 12 cases. American Journal of Gastroenterology 28: 261–264, 1983

    Google Scholar 

  • Felstein D, D’Amico DJ, Hirsch MS, et al. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine. Annals of Internal Medicine 103: 377–380, 1985

    Google Scholar 

  • Forgacs P, Tarshis A, Ma P, et al. Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man. Annals of Internal Medicine 99: 793–794, 1983

    PubMed  CAS  Google Scholar 

  • Frank D, Raicht RF. Intestinal perforation associated with cytomegalovirus infection in patients with acquired immunodeficiency syndrome. American Journal of Gastroenterology 79: 201–205, 1984

    PubMed  CAS  Google Scholar 

  • Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224: 500–502, 1984

    PubMed  CAS  Google Scholar 

  • Gangadharam PRJ, Chandler ER. Activity of antileprosy compounds against Mycobacterium intracellulare in vitro. American Review of Respiratory Diseases 115: 705–708, 1977

    CAS  Google Scholar 

  • Gelmann EP, Preble OT, Stess R, et al. Human lymphoblastoid interferon treatment of Kaposi’s sarcoma in the acquired immune deficiency syndrome: clinical response and prognostic parameters. American Journal of Medicine 78: 737–741, 1985

    PubMed  CAS  Google Scholar 

  • Glaser JB, Morton-Kute L, Berger SR, et al. Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Annals of Internal Medicine 102: 189–193, 1985

    PubMed  CAS  Google Scholar 

  • Golden JA, Sjoerdsma A, Santi DVP. Pneumocystis carinii pneumonia treated with difluoromethylornithine. Western Journal of Medicine 141: 613–623, 1984

    PubMed  CAS  Google Scholar 

  • Gordin FM, Simon GL, Wofsky CB. Adverse reactions to TMP-SMX in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 100: 495–499, 1984

    PubMed  CAS  Google Scholar 

  • Goswami BB, Borek E, Sharma OK, et al. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochemical and Biophysical Research Communications 89: 830–836, 1978

    Google Scholar 

  • Graham Sr WR. Adverse effect of dapsone. International Journal of Dermatology 14: 494–500, 1975

    PubMed  CAS  Google Scholar 

  • Green JB, Sidhu GS, Lewin S, et al. Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Annals of Internal Medicine 97: 539–546, 1982

    Google Scholar 

  • Groopman JE. Recombinant alpha 2 interferon therapy for Kaposi’s sarcoma associated with the acquired immunodeficiency syndrome. Annals of Internal Medicine 100: 671, 1984

    PubMed  CAS  Google Scholar 

  • Hassett JM, Zaroulis CG, Greenberg ML, et al. Bone marrow transplantation in AIDS. New England Journal of Medicine 309: 665, 1983

    PubMed  CAS  Google Scholar 

  • Haverkos HW. Assessment of therapy for Pneumocystis carinii pneumonia. American Journal of Medicine 76: 501–508, 1984

    PubMed  CAS  Google Scholar 

  • Haverkos HW, Gottlieb MS, Killen JY, Edelman R. Classification of HTLV-III/LAV-related diseases. Correspondence. Journal of Infectious Diseases 152: 1095, 1985

    PubMed  CAS  Google Scholar 

  • Hawley DA, Schaefer JF, Schulz DM, et al. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome. American Journal of Pathology 80: 874–877, 1983

    CAS  Google Scholar 

  • Helgstrand E, Erikson B, Johansson NG, et al. Trisodium phosphonoformate, a new antiviral compound. Science 201: 819–821, 1978

    PubMed  CAS  Google Scholar 

  • Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. New England Journal of Medicine 313: 1493–1497, 1985

    PubMed  CAS  Google Scholar 

  • Hughes WT, Feldman S, Chaudhary SC, et al. Comparison of pentamidine isethionate with trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Journal of Pediatrics 92: 285–292, 1978

    PubMed  CAS  Google Scholar 

  • Hughes WT, Smith BL. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrobial Agents and Chemotherapy 26: 436–440, 1984

    PubMed  CAS  Google Scholar 

  • Jacobs JL, Gold JWM, Murray HW, et al. Salmonella infections in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 102: 186–188, 1985

    PubMed  CAS  Google Scholar 

  • Jasmin C, Chermann JC, Raybaud M, et al. In vitro inhibition of murine leukemia and sarcoma viruses by heteropolyanion 5 tungsto 2 antimoniate. Journal of the National Cancer Institute (USA) 53: 469–474, 1974

    CAS  Google Scholar 

  • Jick H. Adverse reactions to trimethoprim-sulfamethoxazole. Review of Infectious Diseases 4: 426–428, 1982

    CAS  Google Scholar 

  • Jolley WB, Hinshaw DB. Minimal effects of ribavirin on the immune system. In Smith & Kirkpatrick (Eds) Ribavirin: a broad spectrum antiviral agent, pp. 73–81, Academic Press, New York, 1980

    Google Scholar 

  • Kaplan MH, Rosen PP, Armstrong D. Cryptococcus in a cancer hospital: clinical and pathological correlates in forty six patients. Cancer 39: 2265–2274, 1977

    PubMed  CAS  Google Scholar 

  • Kimberlin RH, Walker CA. The antiviral compound HPA 23 can prevent scrapie when administered at the time of infection. Archives of Virology 78: 9–18, 1983

    PubMed  CAS  Google Scholar 

  • Klein RS. Oral candidiasis in high risk patients as the initial manifestation of acquired immune deficiency syndrome. New England Journal of Medicine 311: 354–358, 1984

    PubMed  CAS  Google Scholar 

  • Klintmalm G, Lonngvist B, Oberg B, et al. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scandinavian Journal of Infectious Diseases 17: 33–37, 1984

    Google Scholar 

  • Knight V, McClung HW, Wilson SZ, et al. Ribavirin small particle aerosol treatment of influenza. Lancet 2: 945–949, 1981

    PubMed  CAS  Google Scholar 

  • Kovacs A, Forthal DN, Kovacs JA, et al. Disseminated coccidioidomycosis in patients with acquired immune deficiency syndrome. Western Journal of Medicine 140: 447–449, 1984b

    PubMed  CAS  Google Scholar 

  • Kovacs JA, Allegra TC, Chabner BA, et al. Potent in vitro and in vivo antitoxoplasma activity of the new lipid soluble antifolate trimetrexate. Abstract. Clinical Research 34: 522A, 1986

    Google Scholar 

  • Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Annals of Internal Medicine 100: 663–671, 1984a

    PubMed  CAS  Google Scholar 

  • Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 103: 533–538, 1985

    PubMed  CAS  Google Scholar 

  • Krown SE, et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi’s sarcoma. New England Journal of Medicine 308: 1071, 1983

    PubMed  CAS  Google Scholar 

  • Lane HC, Masur H, Longo DL, et al. Partial immune reconstruction in a patient with the acquired immunodeficiency syndrome. New England Journal of Medicine 311: 1099–1103, 1984

    PubMed  CAS  Google Scholar 

  • Lane HC, Masur H, Megill M, et al. Treatment of acquired immunodeficiency syndrome with suramin: clinical, immunological and virological effects, in press, 1986

  • Lau WK, Young LS. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia in adults. New England Journal of Medicine 295: 716–718, 1976

    PubMed  CAS  Google Scholar 

  • Lawson DH, Paice BF. Adverse reactions to trimethoprim-sulfamethoxazole. Review of Infectious Diseases 4: 429–432, 1982

    CAS  Google Scholar 

  • Lerner CW, Tapper ML. Opportunistic infection complicating acquired immunodeficiency syndrome. Medicine 63: 155–164, 1984

    PubMed  CAS  Google Scholar 

  • Levy JA, Hoffman AD, Kramer SM, et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225: 840–842, 1984

    PubMed  CAS  Google Scholar 

  • Masur H, Lane HC, Palestine A, et al. Effect of 9-(l,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Annals of Internal Medicine 104: 41–44, 1986a

    PubMed  CAS  Google Scholar 

  • Masur H, Tuazon CU, Gill V, et al. Effects of combination of clofazimine and ansamycin therapy on Mycobacterium avium intracellulare bacteria in acquired immunodeficiency syndrome patients. Journal of Infectious Diseases, in press, 1986b

  • McCormick JB, Mitchell SW, Getchell JP, et al. Ribavirin suppresses replication of lymphadenopathy associated virus in cultures of human adult T lymphocytes. Lancet 2: 1367–1369, 1984

    PubMed  CAS  Google Scholar 

  • Mintz L, Drew L, Miner RC, et al. Cytomegalovirus infections in homosexual men: an epidemiologic study. Annals of Internal Medicine 99: 326–329, 1983

    PubMed  CAS  Google Scholar 

  • Mitsuya H, Popovic M, Yarchoan R, et al. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTVL-III. Science 226: 172–174, 1984

    PubMed  CAS  Google Scholar 

  • Mitsuya H, Weinhold KJ, Furman PA, et al. 3′-azido-3′dioxythymidine (BWA 509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/Lymphodenopathy associated virus in vitro. Proceedings of the National Academy of Sciences (USA) 82: 7096–7100, 1985

    CAS  Google Scholar 

  • Mitsuyasu R, Volberding P, Groopman J, et al. Bone marrow transplantation from identical twins in the treatment of AIDS and Kaposi’s sarcoma. Journal of Cellular Biochemistry 8 (Suppl.): 19, 1984

    Google Scholar 

  • Navin TR, Juranek DD. Cryptosporidiosis: clinical epidemiologic and parasitologic review. Review of Infectious Diseases 6(3): 313–327, 1984

    CAS  Google Scholar 

  • Oberg B. Antiviral effects of phosphonoformate (PFA, Foscarnet sodium). Pharmacology and Therapeutics 19: 387–394, 1983

    Google Scholar 

  • Pitchenik AE, Cole C, Russell BW, et al. Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non Haitian patients in South Florida. Annals of Internal Medicine 101: 641–645, 1984

    PubMed  CAS  Google Scholar 

  • Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and preAIDS. American Review of Respiratory Diseases 131: 393–396, 1985

    CAS  Google Scholar 

  • Pitlik SD, Fainstein V, Guarda L, et al. Cryptosporidial cholecystitis. New England Journal of Medicine 308: 967, 1983

    PubMed  CAS  Google Scholar 

  • Polsky B, Gold JW, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 104: 38–41, 1986

    PubMed  CAS  Google Scholar 

  • Portnoy D, Whiteside ME, Buckley E, et al. Treatment of intestinal cryptosporidiosis in spiramycin. Annals of Internal Medicine 101: 202–204, 1984

    PubMed  CAS  Google Scholar 

  • Quinnan GV, Masur H, Rook AH, et al. Herpes virus infections in the acquired immune deficiency syndrome. Journal of the American Medical Association 252: 72–77, 1984

    PubMed  Google Scholar 

  • Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. New England Journal of Medicine 314: 131–132, 1986

    PubMed  CAS  Google Scholar 

  • Report of the AIDS Antiviral Agents Workshop. US Public Health Service, 1985

  • Roberts CJ. Coccidioidomycosis in acquired immune deficiency syndrome. American Journal of Medicine 76: 734–736, 1984

    PubMed  CAS  Google Scholar 

  • Rook AH, Masur H, Lane HC, et al. Interleukin-2-enhances the depressed natural killer and cytomegalovirus — specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. Journal of Clinical Investigation 72: 398–403, 1983

    PubMed  CAS  Google Scholar 

  • Rozenbaum W, Dormont D, Spire B, et al. Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet 1: 450–451, 1985

    PubMed  CAS  Google Scholar 

  • Sandstrom EG, Byington RE, Kaplan JC, et al. Inhibition of human T cell lymphotropic virus type III in vitro by phosphonoformate. Lancet 1: 1480–1482, 1985

    PubMed  CAS  Google Scholar 

  • Sarosi GA, Parker JD, Doto IL, et al. Amphotericin B in cryptococcal meningitis: long term results of treatment. Annals of Internal Medicine 71: 1079–1087, 1969

    PubMed  CAS  Google Scholar 

  • Sattler FR, Remington JS. Intravenous trimethoprim-sulfame-thoxazole therapy for Pneumocystis carinii pneumonia. American Journal of Medicine 70: 1215–1221, 1981

    PubMed  CAS  Google Scholar 

  • Shepp DH, Dandliker PS, De Miranda P, et al. Activity of 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine in the treatment of cytomegalovirus pneumonia. Annals of Internal Medicine 103: 368–373, 1985

    PubMed  CAS  Google Scholar 

  • Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Annals of Neurology 14: 403–408, 1983

    PubMed  CAS  Google Scholar 

  • Sohn CC, Schroff RW, Kleiwer KE, et al. Disseminated Mycobacterium avium-intracellulare infection in homosexual men with acquired cell-mediated immunodeficiency: a histologic and immunologic study of two cases. American Journal of Clinical Pathology 79: 247–252, 1982

    Google Scholar 

  • Straus SE, Holly A, Smith BS, et al. Acyclovir for chronic mucocutaneous herpes simplex virus in immunosuppressed patients. Annals of Internal Medicine 96: 270–277, 1982

    PubMed  CAS  Google Scholar 

  • Sundquist B, Oberg B. Phosphonoformate inhibits reverse transcriptase. Journal of General Virology 45: 273–281, 1979

    PubMed  CAS  Google Scholar 

  • Tuazon CU, Delaney M, Simon GL, et al. Utility of GA67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. American Review of Respiratory Diseases 132: 1087–1092, 1985

    CAS  Google Scholar 

  • Utz JP, Garriques IL, Sande MA, et al. Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. Journal of Infectious Diseases 132: 368–373, 1975

    PubMed  CAS  Google Scholar 

  • Wallin J, Lernestedt JO, Lycke E. Treatment of recurrent herpes labialis with trisodium phosphonoformate. In Nelson & Grassi (Eds) Current chemotherapy and infectious diseases, Vol. 2, pp. 1361–1362, American Society for Microbiology, Washington, DC, 1980

    Google Scholar 

  • Wahren B, Oberg B. Reversible inhibition of cytomegalovirus replications by phosphonoformate. Intervirology 14: 7–15, 1980

    PubMed  CAS  Google Scholar 

  • Walzer PD, Perl DP, Krogstad DJ, et al. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic and clinical features. Annals of Internal Medicine 80: 83–93, 1974

    PubMed  CAS  Google Scholar 

  • Wanke C, Tuazon CU, Kovacs A, et al. Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome: diagnosis and response to therapy. American Society of Tropical Medicines and Hygiene, in press, 1986

  • Werner GH, Jasmin C, Chermann JC. Effect of ammonium-5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infection in mice. Journal of General Virology 31: 59–64, 1976

    PubMed  CAS  Google Scholar 

  • Wharton M, Coleman DL, Fitz G, et al. Prospective randomized trial of trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. American Review of Respiratory Diseases 129 (Suppl.): A188, 1984

    Google Scholar 

  • Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. American Journal of Medicine 78: 203–210, 1985

    PubMed  CAS  Google Scholar 

  • Wheat LJ, Small CB. Disseminated histoplasmosis in the acquired immune deficiency syndrome. Correspondence. Archives of Internal Medicine 144: 2147–2149, 1984

    PubMed  CAS  Google Scholar 

  • Winston DJ, Lau WK, Gale RP, et al. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Annals of Internal Medicine 92: 762–769, 1980

    PubMed  CAS  Google Scholar 

  • Wong B, Edwards FF, Kiehn TE, et al. Continuous high grade Mycobacterium intracellulare bacteria in patients with the acquired immunodeficiency syndrome. American Journal of Medicine 78: 35–40, 1985

    PubMed  CAS  Google Scholar 

  • Yarchoan R, Weinhold K, Lyerly HK, et al. Administration of 3′-azido-3′dioxythymidine, an inhibitor of HTLV-III/LAV replication to patients with AIDS or AIDS related complex. Lancet 1: 575–580, 1986

    PubMed  CAS  Google Scholar 

  • Zakowski P, Fligiel S, Berlin GW, et al. Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. Journal of the American Medical Association 248: 2980–2982, 1982

    PubMed  CAS  Google Scholar 

  • Zuger A, Louie E, Holzman RS, et al. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 104: 234–240, 1986

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, George Washington University Medical Center, 2150 Pennsylvania Avenue N.W. Rm 502, Washington, DC, 20037, USA

    Carmelita U. Tuazon & Ann M. Labriola

Authors
  1. Carmelita U. Tuazon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann M. Labriola
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuazon, C.U., Labriola, A.M. Management of Infectious and Immunological Complications of Acquired Immunodeficiency Syndrome(AIDS). Drugs 33, 66–84 (1987). https://doi.org/10.2165/00003495-198733010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198733010-00004

Keywords

Search

Navigation